An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy von Hegerova, Livia T., Leal, Alexis D., Grendahl, Darryl C., Seisler, Drew K., Sorgatz, Kristine M., Anderson, Kari J., Hilger, Crystal R., Loprinzi, Charles L.

Volltext

Pemetrexed-carboplatin salvage therapy in advanced thyroid cancers von Lee, Kenzie K, Morris, 3rd, John C, Kumar, Aditi, Chintakuntlawar, Ashish V, Peskey, Candy, Hilger, Crystal R, Bible, Keith C, Ryder, Mabel

Volltext

Foundation One Genomic Interrogation of Thyroid Cancers in Patients With Metastatic Disease Requiring Systemic Therapy von Iñiguez-Ariza, Nicole M, Jasim, Sina, Ryder, Mabel M, Chintakuntlawar, Ashish V, Morris, John C, Hilger, Crystal R, Menefee, Michael E, Smallridge, Robert C, Karlin, Nina J, Alcaino, Constanza, Bible, Keith C

Volltext

Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer von Iñiguez-Ariza, Nicole M., Ryder, Mabel M., Hilger, Crystal R., Bible, Keith C.

Volltext

OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS von Jasim, Sina, Iniguez-Ariza, Nicole M, Hilger, Crystal R, Chintakuntlawar, Ashish V, Ryder, Mabel M, Morris, 3rd, John C, Bible, Keith C

Volltext

Lenvatinib as a Therapeutic Option in Unresectable Metastatic Pheochromocytoma and Paragangliomas von Hassan Nelson, Lauren, Fuentes-Bayne, Harry, Yin, Jun, Asmus, Erik, Ryder, Mabel, Morris, John C, Hilger, Crystal R, Bible, Keith C, Chintakuntlawar, Ashish V, Rao, Sarika N

Volltext

A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer von Chintakuntlawar, Ashish V., Yin, Jun, Foote, Robert L., Kasperbauer, Jan L., Rivera, Michael, Asmus, Erik, Garces, Nina I., Janus, Jeffrey R., Liu, Minetta, Ma, Daniel J., Moore, Eric J., Morris, John C., Neben-Wittich, Michelle, Price, Daniel L., Price, Katharine A., Ryder, Mabel, Van Abel, Kathryn M., Hilger, Crystal, Samb, Eleyna, Bible, Keith C.

Volltext